Log In
BCIQ
Print this Print this
 

KM 391

  Manage Alerts
Collapse Summary General Information
Company Cellceutix Corp.
DescriptionUndisclosed small molecule
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationAutism
Indication DetailsTreat autism
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today